Stocks Hold Firm After Fed Minutes; PRCT, Applovin, BIRK In Focus

Breadth was solid again with winners beating losers on the Nasda by about 2 to 1. The ratio was nearly 3 to 1 positive on the NYSE. Annual nonfarm payrolls were revised lower by 818,000, but the stock market took the news in stride. Procept soared after the company received FDA clearance for a next-generation surgical robot; Applovin is near the top of a short consolidation; Birkenstock is still in a buy zone ahead of next week’s earnings report.